Codexis, Inc.
CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvā¦ read more
Healthcare
Biotechnology
13 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$2.52
Price+0.80%
$0.02
1Y
Price
Market Cap
$202.322m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$57.164m
-
1y CAGR-
3y CAGR-
5y CAGREarnings
-$64.976m
-
1y CAGR-
3y CAGR-
5y CAGREPS
-$0.83
-
1y CAGR-
3y CAGR-
5y CAGRBook Value
$55.631m
$138.246m
Assets$82.615m
Liabilities$68.980m
DebtDebt to Assets
49.9%
-1.3x
Debt to EBITDAFree Cash Flow
-$67.767m
-
1y CAGR-
3y CAGR-
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company